The pharmaco-economics of peri-operative statin therapyBICCARD, B. M; SEAR, J. W; FOËX, P et al.Anaesthesia. 2005, Vol 60, Num 11, pp 1059-1063, issn 0003-2409, 5 p.Article

The case for statins: has it really been made?THOMPSON, Andrew; TEMPLE, Norman J.Journal of the Royal Society of Medicine. 2004, Vol 97, Num 10, pp 461-464, issn 0141-0768, 4 p.Article

Statines et effets indésirables musculaires : Cardilogie préventive = Statins and muscular side-effectsRODONDI, Nicolas; BROSTEAUX, Christine; RUIZ, Juan et al.Revue médicale suisse. 2010, Vol 6, Num 239, issn 1660-9379, 510-517 [6 p.]Article

Muscle symptoms associated with statins : A series of twenty patientsSOININEN, Kari; NIEMI, Mikko; KILKKI, Esa et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 98, Num 1, pp 51-54, issn 1742-7835, 4 p.Article

IV thrombolysis and statinsENGELTER, S. T; SOINNE, L; ZINI, A et al.Neurology. 2011, Vol 77, Num 9, pp 888-895, issn 0028-3878, 8 p.Article

Statins in dermatologyJOWKAR, Farideh; MOHAMMAD REZA NAMAZI.International journal of dermatology. 2010, Vol 49, Num 11, pp 1235-1243, issn 0011-9059, 9 p.Article

The Acute (Cerebro)Vascular Effects of StatinsPRINZ, Vincent; ENDRES, Matthias.Anesthesia and analgesia. 2009, Vol 109, Num 2, pp 572-584, issn 0003-2999, 13 p.Article

A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial designBICCARD, B. M.Anaesthesia. 2008, Vol 63, Num 2, pp 162-171, issn 0003-2409, 10 p.Article

Statins down underMANT, Andrea; LOWINGER, Jocelyn; HALL, Wayne et al.British journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 125-127, issn 0306-5251, 3 p.Article

Statines en vente libre : Ouvrons le débatMENARD, Joël; POSTEL-VINAY, Nicolas; MAILLARD, Christine et al.Concours médical (Paris). 2006, Vol 128, Num 5, pp 214-216, issn 0010-5309, 3 p.Article

Consequences of Succinylcholine Administration to Patients Using StatinsTURAN, Alparslan; MENDOZA, Maria L; GUPTA, Shipra et al.Anesthesiology (Philadelphia). 2011, Vol 115, Num 1, pp 28-35, issn 0003-3022, 8 p.Article

Statin induced myopathySATHASIVAM, Sivakumar; LECKY, Bryan.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7679, pp 1159-1162, issn 0959-8146, 4 p.Article

Statin Therapy within the Perioperative PeriodLE MANACH, Yannick; CORIAT, Pierre; COLLARD, Charles D et al.Anesthesiology (Philadelphia). 2008, Vol 108, Num 6, pp 1141-1146, issn 0003-3022, 6 p.Article

The THRombolysis and STatins (THRaST) studyCAPPELLARI, Manuel; BOVI, Paolo; TASSINARI, Tiziana et al.Neurology. 2013, Vol 80, Num 7, pp 655-661, issn 0028-3878, 7 p.Article

Exploiting a Physiological Regulator to Improve the Efficacy and Safety of StatinsGILL, Saloni; BROWN, Andrew J.Cardiovascular drugs and therapy. 2011, Vol 25, Num 2, pp 183-185, issn 0920-3206, 3 p.Article

What is a relevant statin concentration in cell experiments claiming pleiotropic effects?BJÖRKHEM-BERGMAN, Linda; LINDH, Jonatan D; BERGMAN, Peter et al.British journal of clinical pharmacology. 2011, Vol 72, Num 1, pp 164-165, issn 0306-5251, 2 p.Article

Sur quels critères prescrire des statines : chez la personne âgée ?DURANT, Richard.Concours médical (Paris). 2006, Vol 128, Num 4, pp 173-177, issn 0010-5309, 5 p.Article

Potential vascular benefits of statinsKINLAY, Scott.The American journal of medicine. 2005, Vol 118, Num 12A, pp 62S-67S, issn 0002-9343Conference Paper

Outcomes after thrombolysis in AIS according to prior statin use: A registry and reviewMESEGUER, Elena; MAZIGHI, Mikael; OLIVOT, Jean-Marc et al.Neurology. 2012, Vol 79, Num 17, pp 1817-1823, issn 0028-3878, 7 p.Article

Relation of Statin Nonadherence and Treatment IntensificationPITTMAN, Donald G; FENTON, Cynthia; CHEN, William et al.The American journal of cardiology. 2012, Vol 110, Num 10, pp 1459-1463, issn 0002-9149, 5 p.Article

Efficacité et efficience des hypolipémiants Une analyse centrée sur les statinesAngéiologie (Paris). 2010, Vol 62, Num 4, pp 24-31, issn 0003-3049, 8 p.Article

Do the cholesterol-lowering properties of statins affect cancer risk?SOLOMON, Keith R; FREEMAN, Michael R.Trends in endocrinology and metabolism. 2008, Vol 19, Num 4, pp 113-121, issn 1043-2760, 9 p.Article

Statin myopathies: pathophysiologic and clinical perspectivesBAKER, Steven K; TARNOPOLSKY, Mark A.Clinical and investigative medicine. 2001, Vol 24, Num 5, pp 258-272, issn 0147-958XConference Paper

Rarity of Anti―3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Antibodies in Statin Users, Including Those With Self-Limited Musculoskeletal Side EffectsMAMMEN, Andrew L; PAK, Katherine; WILLIAMS, Emma K et al.Arthritis care and research. 2012, Vol 64, Num 2, pp 269-272, issn 0893-7524, 4 p.Article

Statins and over-the-counter availabilitySTROM, Brian L.The New England journal of medicine. 2005, Vol 352, Num 14, pp 1403-1405, issn 0028-4793, 3 p.Article